Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20864138)

  • 1. [Morphological classification of glioblastomas].
    Figarella-Branger D; Bouvier C; Moroch J; Michalak S; F Burel-Vandenbos
    Neurochirurgie; 2010 Dec; 56(6):459-63. PubMed ID: 20864138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic implications of IDH1-R132H and OLIG2 expression patterns in rare and challenging glioblastoma variants.
    Joseph NM; Phillips J; Dahiya S; M Felicella M; Tihan T; Brat DJ; Perry A
    Mod Pathol; 2013 Mar; 26(3):315-26. PubMed ID: 23041832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Established and emerging variants of glioblastoma multiforme: review of morphological and molecular features.
    Karsy M; Gelbman M; Shah P; Balumbu O; Moy F; Arslan E
    Folia Neuropathol; 2012; 50(4):301-21. PubMed ID: 23319187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation among pathology, genotype, and patient outcomes in glioblastoma.
    Homma T; Fukushima T; Vaccarella S; Yonekawa Y; Di Patre PL; Franceschi S; Ohgaki H
    J Neuropathol Exp Neurol; 2006 Sep; 65(9):846-54. PubMed ID: 16957578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
    Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
    Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological spectrum in recurrences of glioblastoma multiforme.
    Marucci G; Fabbri PV; Morandi L; De Biase D; Di Oto E; Tallini G; Sturiale C; Franceschi E; Frezza GP; Foschini MP
    Pathologica; 2015 Mar; 107(1):1-8. PubMed ID: 26591624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histomolecular classification of adult diffuse gliomas: the diagnostic value of immunohistochemical markers.
    Figarella-Branger D; Maues de Paula A; Colin C; Bouvier C
    Rev Neurol (Paris); 2011 Oct; 167(10):683-90. PubMed ID: 21889777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Well-differentiated pediatric glial neoplasms with features of oligodendroglioma, angiocentric glioma and dysembryoplastic neuroepithelial tumors: a morphological diagnostic challenge.
    Keser H; Barnes M; Moes G; Lee HS; Tıhan T
    Turk Patoloji Derg; 2014; 30(1):23-9. PubMed ID: 24448703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.
    Nutt CL; Mani DR; Betensky RA; Tamayo P; Cairncross JG; Ladd C; Pohl U; Hartmann C; McLaughlin ME; Batchelor TT; Black PM; von Deimling A; Pomeroy SL; Golub TR; Louis DN
    Cancer Res; 2003 Apr; 63(7):1602-7. PubMed ID: 12670911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioblastoma: pathology, molecular mechanisms and markers.
    Aldape K; Zadeh G; Mansouri S; Reifenberger G; von Deimling A
    Acta Neuropathol; 2015 Jun; 129(6):829-48. PubMed ID: 25943888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Histological and molecular classification of gliomas].
    Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
    Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathology, classification, and grading of gliomas.
    Kleihues P; Soylemezoglu F; Schäuble B; Scheithauer BW; Burger PC
    Glia; 1995 Nov; 15(3):211-21. PubMed ID: 8586458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression-based molecular diagnostic system for malignant gliomas is superior to histological diagnosis.
    Shirahata M; Iwao-Koizumi K; Saito S; Ueno N; Oda M; Hashimoto N; Takahashi JA; Kato K
    Clin Cancer Res; 2007 Dec; 13(24):7341-56. PubMed ID: 18094416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oligodendroglial and neuronal component in glioblastomas: possible relation with prognosis].
    Pinto LW; Chimelli L
    Arq Neuropsiquiatr; 2004 Dec; 62(4):1074-8. PubMed ID: 15608972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of microvascular patterns via cluster analysis reveals their prognostic significance in glioblastoma.
    Chen L; Lin ZX; Lin GS; Zhou CF; Chen YP; Wang XF; Zheng ZQ
    Hum Pathol; 2015 Jan; 46(1):120-8. PubMed ID: 25455996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleolar organizer regions (AgNORs) in astrocytic tumors.
    Pedal WP; Warzok RW; Hufnagl P; Roth K
    Zentralbl Pathol; 1994 Mar; 140(1):89-94. PubMed ID: 7515679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioblastoma.
    Miller CR; Perry A
    Arch Pathol Lab Med; 2007 Mar; 131(3):397-406. PubMed ID: 17516742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical markers for prognosis of cerebral glioblastomas.
    Korshunov A; Golanov A; Sycheva R
    J Neurooncol; 2002 Jul; 58(3):217-36. PubMed ID: 12187957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The definition of primary and secondary glioblastoma.
    Ohgaki H; Kleihues P
    Clin Cancer Res; 2013 Feb; 19(4):764-72. PubMed ID: 23209033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. If it is Not a Glioblastoma, Then What is it? A Differential Diagnostic Review.
    Gokden M
    Adv Anat Pathol; 2017 Nov; 24(6):379-391. PubMed ID: 28885262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.